Administración de Empresas
Departamento
![Foto de Administración de Empresas](/img/uploaded/F604C5D6976D4D722ACE810ACE624981.jpg)
![Foto de Uppsala University](/img/noimage_org.png)
Uppsala University
Upsala, SueciaPublicaciones en colaboración con investigadores/as de Uppsala University (5)
2024
-
A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
Upsala journal of medical sciences, Vol. 129
2022
-
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, Núm. 1, pp. 31-38
-
Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study
Upsala Journal of Medical Sciences, Vol. 127
2021
-
Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study
Advances in Therapy, Vol. 38, Núm. 9, pp. 4695-4708
2019
-
Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: Estimates from Swedish population-based register data
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 5, Núm. 3, pp. 225-232